The challenge of postcovid syndrome (PCS) is of great interest due to its wide distribution and variety of clinical signs. The main neurological signs of PCS are discussed. Data on the presumptive mechanisms forming PCS are presented. The potential for using the drug Mexidol to treat patients with PCS is addressed.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789305 | PMC |
http://dx.doi.org/10.1007/s11055-022-01324-1 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!